Philip Owens

Dr. Philip Owens


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2014 in Oncogene
Verified
Journal Article
Open access
PDF file
POPhilip Owens
Philip Owens
MPM W Pickup
M W Pickup
SNS V Novitskiy
S V Novitskiy
JGJ M Giltnane
J M Giltnane
AGA E Gorska
A E Gorska
HMH L Moses
H L Moses
Bone morphogenetic proteins (BMPs) are secreted cytokines/growth factors that have differing roles in cancer. BMPs are overexpressed in human breast cancers, but loss of BMP signaling in mammary carcinomas can accelerate metastasis. We show that human breast cancers display active BMP signaling, which is rarely downregulated or homozygously deleted. We hypothesized that systemic inhibition of BMP signaling in both the tumor and the surrounding microenvironment could prevent tumor progression and metastasis. To test this hypothesis, we used DMH1, a BMP antagonist, in MMTV.PyVmT expressing mice. Treatment with DMH1 reduced lung metastasis and the tumors were less proliferative and more apoptotic. In the surrounding tumor microenvironment, treatment with DMH1 altered fibroblasts, lymphatic vessels and macrophages to be less tumor promoting. These results indicate that inhibition of BMP signaling may successfully target both the tumor and the surrounding microenvironment to reduce tumor burden and metastasis.

15 August 2016 in Biochemical Society Transactions
Verified
Journal Article
Closed access
PDF file
PJPawina Jiramongkolchai
Pawina Jiramongkolchai
POPhilip Owens
Philip Owens
CHCharles Hong
Charles Hong
Bone morphogenetic proteins (BMPs) belong to the transforming growth factor-β (TGF-β) family signalling pathway. Similar to TGF-β, the complex roles of BMPs in development and disease are demonstrated by their dichotomous roles in various cancers and cancer stages. Although early studies implicated BMP signalling in tumour suppressive phenotypes, the results of more recent experiments recognize BMPs as potent tumour promoters. Many of these complexities are becoming illuminated by understanding the role of BMPs in their contextual role in unique cell types of cancer and the impact of their surrounding tumour microenvironment. Here we review the emerging roles of BMP signalling in cancer, with a focus on the molecular underpinnings of BMP signalling in individual cancers as a valid therapeutic target for cancer prevention and treatment.

2 June 2016 in Current Osteoporosis Reports
Verified
Journal Article
Closed access
PDF file
DBDenise Buenrostro
Denise Buenrostro
PMPatrick L. Mulcrone
Patrick L. Mulcrone
POPhilip Owens
Philip Owens
Julie RhoadesJulie Rhoades
Julie Rhoades

10 June 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
MPMichael W. Pickup
Michael W. Pickup
LHLaura D. Hover
Laura D. Hover
YGYan Guo
Yan Guo
AGAgnieszka E. Gorska
Agnieszka E. Gorska
ACAnna Chytil
Anna Chytil
POPhilip Owens
Philip Owens
Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis

23 August 2014 in Molecular Oncology
Verified
Journal Article
Open access
MPMichael W. Pickup
Michael W. Pickup
LHLaura D. Hover
Laura D. Hover
EPEleanor R. Polikowsky
Eleanor R. Polikowsky
ACAnna Chytil
Anna Chytil
AGAgnieszka E. Gorska
Agnieszka E. Gorska
POPhilip Owens
Philip Owens
Bone Morphogenetic Protein (BMP) receptors mediate a diverse range of signals to regulate both development and disease. BMP activity has been linked to both tumor promoting and suppressive functions in both tumor cells and their surrounding microenvironment. We sought to investigate the requirement for BMPR2 in stromal fibroblasts during mammary tumor formation and metastasis. We utilized FSP1 (Fibroblast Specific Protein‐1) promoter driven Cre to genetically delete BMPR2 in mice expressing the MMTV.PyVmT mammary carcinoma oncogene. We found that abrogation of stromal BMPR2 expression via FSP1 driven Cre resulted in increased tumor metastasis. Additionally, similar to epithelial BMPR2 abrogation, stromal loss of BMPR2 results in increased inflammatory cell infiltration. We proceeded to isolate and establish fibroblast cell lines without BMPR2 and found a cell autonomous increase in inflammatory cytokine secretion. Fibroblasts were co‐implanted with syngeneic tumor cells and resulted in accelerated tumor growth and increased metastasis when fibroblasts lacked BMPR2. We observed that the loss of BMPR2 results in increased chemokine expression, which facilitates inflammation by a sustained increase in myeloid cells. The chemokines increased in BMPR2 deleted cells correlated with poor outcome in human breast cancer patients. We conclude that BMPR2 has tumor suppressive functions in the stroma by regulating inflammation.

1 November 2015 in Cancer Letters
Verified
Journal Article
Closed access
LHLaura D. Hover
Laura D. Hover
CYChristian D. Young
Christian D. Young
NBNeil E. Bhola
Neil E. Bhola
AWAndrew J. Wilson
Andrew J. Wilson
DKDineo Khabele
Dineo Khabele
POPhilip Owens
Philip Owens